1471 related articles for article (PubMed ID: 10100525)
1. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
4. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic gentamicin therapy for Ménière's disease.
Hirsch BE; Kamerer DB
Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
[TBL] [Abstract][Full Text] [Related]
8. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
Martin E; Perez N
Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
[TBL] [Abstract][Full Text] [Related]
9. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
10. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
11. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
13. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
14. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic gentamicin in Ménière's disease: results of therapy.
Murofushi T; Halmagyi GM; Yavor RA
Am J Otol; 1997 Jan; 18(1):52-7. PubMed ID: 8989952
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
Quaranta A; Aloisi A; De Benedittis G; Scaringi A
Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
Atlas JT; Parnes LS
Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
Abou-Halawa AS; Poe DS
Otol Neurotol; 2002 Jul; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
[TBL] [Abstract][Full Text] [Related]
19. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
[TBL] [Abstract][Full Text] [Related]
20. [Intratympanic gentamicin treatment for intractable Menière's disease].
Gilony D; Wolf M; Kronenberg J
Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]